A detailed history of Palisade Asset Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Palisade Asset Management, LLC holds 62 shares of OGN stock, worth $466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62
Holding current value
$466
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025

BUY
$8.4 - $10.85 $520 - $672
62 New
62 $0
Q1 2024

May 01, 2024

BUY
$13.78 - $18.8 $1,736 - $2,368
126 New
126 $2,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Palisade Asset Management, LLC Portfolio

Follow Palisade Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Asset Management, LLC with notifications on news.